CRISPR Therapeutics AG Statistics
Total Valuation
CRSP has a market cap or net worth of $4.52 billion. The enterprise value is $3.05 billion.
| Market Cap | 4.52B |
| Enterprise Value | 3.05B |
Important Dates
The next estimated earnings date is Tuesday, May 14, 2024, after market close.
| Earnings Date | May 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CRSP has 84.88 million shares outstanding. The number of shares has increased by 1.90% in one year.
| Shares Outstanding | 84.88M |
| Shares Change (YoY) | +1.90% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 1.86% |
| Owned by Institutions (%) | 68.74% |
| Float | 78.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 23.36 |
| PS Ratio | 12.17 |
| Forward PS | 40.82 |
| PB Ratio | 2.40 |
| P/FCF Ratio | n/a |
| PEG Ratio | -0.21 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.54, with a Debt / Equity ratio of 0.13.
| Current Ratio | 17.54 |
| Quick Ratio | 17.51 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -8.40% and return on invested capital (ROIC) is -10.49%.
| Return on Equity (ROE) | -8.40% |
| Return on Assets (ROA) | -7.00% |
| Return on Capital (ROIC) | -10.49% |
| Revenue Per Employee | $912,054 |
| Profits Per Employee | -$377,420 |
| Employee Count | 407 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CRSP has paid $2.89 million in taxes.
| Income Tax | 2.89M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.91% in the last 52 weeks. The beta is 1.74, so CRSP's price volatility has been higher than the market average.
| Beta (1Y) | 1.74 |
| 52-Week Price Change | -4.91% |
| 50-Day Moving Average | 66.20 |
| 200-Day Moving Average | 59.36 |
| Relative Strength Index (RSI) | 34.23 |
| Average Volume (30 Days) | 1,711,432 |
Short Selling Information
The latest short interest is 14.74 million, so 17.37% of the outstanding shares have been sold short.
| Short Interest | 14.74M |
| Short Previous Month | 14.76M |
| Short % of Shares Out | 17.37% |
| Short % of Float | 18.70% |
| Short Ratio (days to cover) | 11.42 |
Income Statement
In the last 12 months, CRSP had revenue of $371.21 million and -$153.61 million in losses. Loss per share was -$1.94.
| Revenue | 371.21M |
| Gross Profit | 371.21M |
| Operating Income | -222.54M |
| Pretax Income | -150.72M |
| Net Income | -153.61M |
| EBITDA | -130.89M |
| EBIT | -150.72M |
| Loss Per Share | -$1.94 |
Balance Sheet
The company has $1.71 billion in cash and $238.63 million in debt, giving a net cash position of $1.47 billion or $17.28 per share.
| Cash & Cash Equivalents | 1.71B |
| Total Debt | 238.63M |
| Net Cash | 1.47B |
| Net Cash Per Share | $17.28 |
| Equity / Book Value | 1.88B |
| Book Value Per Share | 22.18 |
| Working Capital | 1.80B |
Cash Flow
In the last 12 months, operating cash flow was -$260.38 million and capital expenditures -$9.47 million, giving a free cash flow of -$269.85 million.
| Operating Cash Flow | -260.38M |
| Capital Expenditures | -9.47M |
| Free Cash Flow | -269.85M |
| FCF Per Share | -$3.41 |
Margins
Gross margin is 100.00%, with operating and profit margins of -59.95% and -41.38%.
| Gross Margin | 100.00% |
| Operating Margin | -59.95% |
| Pretax Margin | -40.60% |
| Profit Margin | -41.38% |
| EBITDA Margin | -35.26% |
| EBIT Margin | -40.60% |
| FCF Margin | -72.69% |
Dividends & Yields
CRSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.90% |
| Shareholder Yield | -1.90% |
| Earnings Yield | -3.40% |
| FCF Yield | -5.98% |
Analyst Forecast
The average price target for CRSP is $81.44, which is 53.04% higher than the current price. The consensus rating is "Buy".
| Price Target | $81.44 |
| Price Target Difference | 53.04% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 42.04% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRSP has an Altman Z-Score of 8.1 and a Piotroski F-Score of 2.
| Altman Z-Score | 8.1 |
| Piotroski F-Score | 2 |